Wells, A. F., Parrino, J., Mangan, E. K., Paccaly, A., Lin, Y., Xu, C., . . . Torri, A. (2019). Immunogenicity of Sarilumab Monotherapy in Patients with Rheumatoid Arthritis Who Were Inadequate Responders or Intolerant to Disease-Modifying Antirheumatic Drugs. Rheumatol Ther.
Chicago-стиль цитированияWells, Alvin F., et al. "Immunogenicity of Sarilumab Monotherapy in Patients With Rheumatoid Arthritis Who Were Inadequate Responders or Intolerant to Disease-Modifying Antirheumatic Drugs." Rheumatol Ther 2019.
MLA-цитированиеWells, Alvin F., et al. "Immunogenicity of Sarilumab Monotherapy in Patients With Rheumatoid Arthritis Who Were Inadequate Responders or Intolerant to Disease-Modifying Antirheumatic Drugs." Rheumatol Ther 2019.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.